Nandrolone Phenylpropionate 100mg/ml 10ml Vial by Kim Pharma

Usage

1. Calculate your injection volume from the pharmacokinetic schedule.: With a half-life of approximately 2.5–4 days, every-two-to-three-day injections are required to maintain above-threshold plasma nandrolone. Determine your target weekly dose first, then divide evenly across your chosen injection days.
2. Draw the correct volume using a standard 1ml or 2ml luer-lock syringe.: At 100mg/ml, a 0.5ml draw equals 50mg and a 1.0ml draw equals 100mg — confirm the volume before injection to honour your pharmacokinetic plan.
3. Warm the vial briefly if ambient temperature has increased oil viscosity.: Kim Pharma's carrier oil formulation is calibrated for consistent depot release, but slightly elevated vial temperature aids smooth drawing and reduces dead-volume loss in the needle hub.
4. Rotate injection sites systematically across each injection week.: Gluteus medius, vastus lateralis, and deltoid sites should be cycled; repeated depot formation at a single site can alter local blood flow and therefore affect the release rate from that depot.
5. Inject at your scheduled clock interval — not opportunistically.: Because the phenylpropionate half-life is shorter than decanoate, delayed injections create genuine plasma troughs; consistency in timing is more critical than with long-ester protocols.
6. Log your final injection date and calculate PCT start.: Phenylpropionate ester clearance from the injection depot is sufficiently rapid that SERM-based post-cycle therapy can begin approximately 5–7 days after the last dose — plan this date before the cycle begins.

Warnings

Frequently asked questions

What is the exact half-life of nandrolone phenylpropionate and how was it determined?

The terminal plasma half-life of nandrolone phenylpropionate is consistently reported in a 2.5–4 day range across HPLC-based pharmacokinetic analyses of intramuscular esterified nandrolone formulations. The figure reflects esterase-mediated cleavage rate at the depot combined with free nandrolone's own distribution and elimination kinetics. Individual variation in local esterase activity and carrier oil viscosity can shift this range slightly within the stated window.

How does the phenylpropionate release curve differ from nandrolone decanoate in practical terms?

The phenylpropionate ester's shorter carbon chain produces a faster depot-to-plasma release rate and a shorter terminal half-life compared to decanoate. In practice, this means plasma nandrolone rises and falls more rapidly, requiring injections every two to three days rather than the once-weekly schedule common with decanoate. The trade-off is greater pharmacokinetic control and a significantly shorter clearance window when the cycle ends.

What injection frequency is pharmacokinetically appropriate for NPP with a 2.5–4 day half-life?

A Monday-Wednesday-Friday or every-other-day schedule is pharmacokinetically appropriate for nandrolone phenylpropionate. With a half-life in the 2.5–4 day range, injecting every 48–72 hours prevents plasma nandrolone from falling below the functional anabolic threshold between doses. Less frequent protocols — such as twice weekly — produce more pronounced trough concentrations and wider peak-to-trough amplitude across the injection week.

Can I draw accurate doses from a 10ml vial using a standard insulin syringe at 100mg/ml concentration?

Yes. Kim Pharma's 100mg/ml concentration is the lowest in the comparative NPP product group, which means each 0.1ml graduation on a standard 1ml syringe corresponds to 10mg — a straightforward relationship that makes small dose adjustments easy to measure precisely. For doses of 50mg or 75mg, a 1ml luer-lock syringe with 0.1ml graduations allows accurate measurement without the rounding errors that arise with higher-concentration formulations.

How should a 10ml Kim Pharma NPP vial be stored after the first draw, and does the rubber septum affect sterility?

After the first draw, the vial should be stored in a cool, dark location — between 15°C and 25°C — away from direct light and heat, which can degrade both the carrier oil and the ester bond stability over time. The multi-dose rubber septum is designed to reseal after each needle puncture; wipe the septum with an alcohol swab before every draw. Refrigeration is not required but can extend useful shelf life when a single vial spans many weeks of injections. (2) angle_used

Manufacturer

Kim Pharma's distribution and logistics infrastructure for its injectable anabolic range is structured around a core operational objective: ensuring that vials reaching the end user carry the same analytical profile as vials leaving the filling line. This objective shapes decisions at every point in the supply chain — from batch-release hold protocols, which prevent distribution until HPLC potency data and LAL endotoxin results are returned and reviewed, through to cold-chain handling guidelines issued to regional stockists to preserve carrier oil integrity and ester stability during transit. The 10ml multi-dose vial format chosen for this Nandrolone Phenylpropionate product is not incidental; it is a logistics-aware packaging decision that reduces per-shipment unit count without compromising the per-dose volume an athlete needs across a structured multi-week protocol. Kim Pharma's stockist network is documented and tiered, with batch traceability maintained through distribution so that a customer requiring a Certificate of Analysis for a specific lot number can obtain that document through the same channel from which the product was sourced — a supply-chain transparency standard that distinguishes batch-documented brands from those where analytical verification exists only as a label claim.